OPHTHA FUTUR
DEAD

Serial Number

79201974

Owner

Pharmpur GmbH

Attorney

Paul D. Bianco

Filing Date

Sep 1, 2016

Add to watchlist:

No watchlists yet
View on USPTO

OPHTHA FUTUR Trademark

Serial Number: 79201974 • Registration: 5372133

OPHTHA FUTUR is a trademark filed by Pharmpur GmbH on September 1, 2016. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Pharmpur GmbH

Messerschmittring 33,

Entity Type: 99

Trademark Details

Filing Date

September 1, 2016

Registration Date

January 9, 2018

Published for Opposition

October 24, 2017

Cancellation Date

July 26, 2024

Goods & Services

Medicine, in particular ophthalmologic preparations; ocular pharmaceuticals, pharmaceuticals to support ophthalmic surgery

Surgical, medical, dental and veterinary apparatus and instruments for use in ophthalmic treatment and ophthalmic surgery, cataract removal equipment, vitrectomy equipment and endoscopes; artificial limbs; artificial eyes; artificial teeth; orthopedic articles, namely, silicone orthopedic devices for therapeutic use, silicone orthopedic implants, pillows and compression pads for orthopedic use, elastic bandages and plaster bandages for orthopedic purposes, synthetic supportive bandages and orthopedic support bandages; suture materials

Scientific and technological services, namely, scientific research, analysis, testing, quality management building and product development, in the field of treatment of eye diseases and ophthalmic surgery; research relating to technology, in particular chemical technological research; advisory services relating to technological research in the field of chemical, physical, biological and technological research for the development of ophthalmic drugs and medical devices; provision of information relating to technological research in the field of ophthalmic pharmaceuticals, materials and medical devices used in ophthalmology; technological services in the field of ophthalmology, namely, technological consultation, technological information, product development, development of manufacturing equipment used for ophthalmic drugs and products and advisory in the field of site planning for manufacturing of ophthalmic devices; chemical research; chemical research and analysis services; research on the subject of pharmaceuticals; pharmaceutical drug development services; pharmaceutical research and development; medical and pharmaceutical research and development; consultancy pertaining to pharmacology, in particular ophthalmology; conducting clinical trials for pharmaceutical products; product evaluations and product registration, reports and post market follow up of ophthalmic products in international markets, evaluations of scientific projects related to the ophthalmic industry services for assessing the efficiency of pharmaceuticals, planning and management of quality relevant activities in the field of ophthalmic manufacturing; research and development for the pharmaceutical industry; providing information about the results of clinical trials for pharmaceutical products; information technology consultancy services for the pharmaceutical and healthcare industries; all aforementioned services particularly relating to ophthalmology and ophthalmologic preparations

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
Jul 11, 2025 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Jun 24, 2025 INTS
INVALIDATION PROCESSED
Jun 24, 2025 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Mar 26, 2025 INTR
CANCELLED SECTION 71
Jul 26, 2024 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jan 9, 2023 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Oct 5, 2018 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 1, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 17, 2018 FICS
FINAL DISPOSITION PROCESSED
Apr 17, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 9, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Jan 9, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 24, 2017 NPUB
PUBLISHED FOR OPPOSITION
Oct 24, 2017 PUBO
NOTIFICATION PROCESSED BY IB
Oct 21, 2017 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 4, 2017 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Oct 4, 2017 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 4, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 12, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 7, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 7, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 7, 2017 TROA
REFUSAL PROCESSED BY IB
Mar 25, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 7, 2017 RFCS
REFUSAL PROCESSED BY MPU
Mar 7, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 7, 2017 RFCR
NON-FINAL ACTION WRITTEN
Mar 6, 2017 CNRT
APPLICATION FILING RECEIPT MAILED
Feb 28, 2017 MAFR
ASSIGNED TO EXAMINER
Feb 24, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 24, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 23, 2017 REPR